Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckCOHEN, Ezra E. W.Journal of clinical oncology. 2006, Vol 24, Num 17, pp 2659-2665, issn 0732-183X, 7 p.Article

Treatment of metastatic urothelial cancer in the post-MVAC eraCOHEN, Ezra E. W; STADLER, Walter M.World journal of urology (Print). 2001, Vol 19, Num 2, pp 126-132, issn 0724-4983Article

Epidermal growth factor receptor directed therapy in head and neck cancerCHOONG, Nicholas W; COHEN, Ezra E. W.Critical reviews in oncology/hematology. 2006, Vol 57, Num 1, pp 25-43, issn 1040-8428, 19 p.Article

Targeting Angiogenesis in Head and Neck CancerSEIWERT, Tanguy Y; COHEN, Ezra E. W.Seminars in oncology. 2008, Vol 35, Num 3, pp 274-285, issn 0093-7754, 12 p.Article

Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancerCOHEN, Ezra E. W; VOKES, Everett E.Hematology/oncology clinics of North America. 2004, Vol 18, Num 1, issn 0889-8588, ix, 81-90 [11 p.]Article

Novel therapeutic targets in squamous cell carcinoma of the head and neckCOHEN, Ezra E. W.Seminars in oncology. 2004, Vol 31, Num 6, pp 755-768, issn 0093-7754, 14 p.Article

The expanding role of systemic therapy in head and neck cancerCOHEN, Ezra E. W; LINGEN, Mark W; VOKES, Everett E et al.Journal of clinical oncology. 2004, Vol 22, Num 9, pp 1743-1752, issn 0732-183X, 10 p.Article

New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor InhibitorsCHEN, Lucy F; COHEN, Ezra E. W; GRANDIS, Jennifer R et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2489-2495, issn 1078-0432, 7 p.Article

Head and Neck CancerVOKES, Everett E; COHEN, Ezra E. W; GRANDIS, Jennifer R et al.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, 129 p.Serial Issue

Modifiable Risk Behaviors in Patients With Head and Neck CancerSIVASITHAMPARAM, Janani; VISK, Carly A; COHEN, Ezra E. W et al.Cancer. 2013, Vol 119, Num 13, pp 2419-2426, issn 0008-543X, 8 p.Article

Standard and Emerging Therapeutic Approaches for Thyroid MalignanciesBROWN, Rebecca L.Seminars in oncology. 2008, Vol 35, Num 3, pp 298-308, issn 0093-7754, 11 p.Article

Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck CancerCOHEN, Ezra E. W; HARAF, Daniel J; WITT, Mary Ellyn et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3336-3343, issn 0732-183X, 8 p.Article

Current and Emerging Standards of Concomitant ChemoradiotherapyADELSTEIN, David J; RODRIGUEZ, Cristina P.Seminars in oncology. 2008, Vol 35, Num 3, pp 211-220, issn 0093-7754, 10 p.Article

Novel Imaging Approaches to Head and Neck CancerKROHN, Kenneth A; YEUH, Bevan.Seminars in oncology. 2008, Vol 35, Num 3, pp 262-273, issn 0093-7754, 12 p.Article

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialCOHEN, Ezra E. W; HARAF, Daniel J; KIES, Merrill S et al.Journal of clinical oncology. 2006, Vol 24, Num 21, pp 3438-3444, issn 0732-183X, 7 p.Article

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFRCOHEN, Ezra E. W; LINGEN, Mark W; CLARK, John R et al.Clinical cancer research. 2005, Vol 11, Num 22, pp 8105-8108, issn 1078-0432, 4 p.Article

AIRWAY MANAGEMENT BEFORE CHEMORADIATION FOR ADVANCED HEAD AND NECK CANCERLANGERMAN, Alexander; PATEL, Riddhi M; COHEN, Ezra E. W et al.Head & neck. 2012, Vol 34, Num 2, pp 254-259, issn 1043-3074, 6 p.Article

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neckCOHEN, Ezra E. W; ROSEN, Fred; STADLER, Walter M et al.Journal of clinical oncology. 2003, Vol 21, Num 10, pp 1980-1987, issn 0732-183X, 8 p.Article

Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapyCOHEN, Ezra E. W; AHMED, Omar; KOCHERGINSKY, Masha et al.Oral oncology (1997). 2013, Vol 49, Num 10, pp 1025-1031, issn 1368-8375, 7 p.Article

NOVEL MOLECULAR TARGETED THERAPIES FOR REFRACTORY THYROID CANCERPEREZ, Cesar A; SANTOS, Edgardo S; ARANGO, Belisario A et al.Head & neck. 2012, Vol 34, Num 5, pp 736-745, issn 1043-3074, 10 p.Article

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid CancerKURZROCK, Razelle; SHERMAN, Steven I; HONG, David S et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2660-2666, issn 0732-183X, 7 p.Article

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid TumorsRINI, Brian I; SCHILLER, Joan H; KIM, Sinil et al.Clinical cancer research (Print). 2011, Vol 17, Num 11, pp 3841-3849, issn 1078-0432, 9 p.Article

The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell CarcinomaSEIWERT, Tanguy Y; JAGADEESWARAN, Ramasamy; MARTIN, Leslie et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 3021-3031, issn 0008-5472, 11 p.Article

The Role of Neck Dissection in the Combined Modality Therapy SettingBROWN, Kimberly M; LANGO, Miriam; RIDGE, John A et al.Seminars in oncology. 2008, Vol 35, Num 3, pp 229-235, issn 0093-7754, 7 p.Article

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasiaRUDIN, Charles M; COHEN, Ezra E. W; PAPADIMITRAKOPOULOU, Vassiliki A et al.Journal of clinical oncology. 2003, Vol 21, Num 24, pp 4546-4552, issn 0732-183X, 7 p.Article